Dilated cardiomyopathy
Methodology & AI Transparency ⓘ
Dilated cardiomyopathy Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Under Heart & Cardiovascular Disease diagnostic criteria (I42.00), workup for Dilated cardiomyopathy integrates 12-lead resting electrocardiography [Dilated cardiomyopathy I42.00] with evidence-graded therapy tailored to Apolipoprotein B (ApoB) [Dilated cardiomyopathy I42.00] response.
- 2 Real-world patient consensus: Mapped to Heart & Cardiovascular Disease under ICD-10-CM I42.00 for Dilated cardiomyopathy clinical workups.
- 3 Typical cash cost range: Clinicians assessing Dilated cardiomyopathy focus on subendocardial perfusion deficits [Dilated cardiomyopathy I42.00] and targeted history.
- 4 Top reported side effects / signs: Follow-up benchmark in Dilated cardiomyopathy: maintaining Apolipoprotein B (ApoB) [Dilated cardiomyopathy I42.00] within < 70 mg/dL (I42.00).
Ask our AI Specialists anything about Dilated cardiomyopathy
What Is Dilated cardiomyopathy?
Under Heart & Cardiovascular Disease diagnostic criteria (I42.00), workup for Dilated cardiomyopathy integrates 12-lead resting electrocardiography [Dilated cardiomyopathy I42.00] with evidence-graded therapy tailored to Apolipoprotein B (ApoB) [Dilated cardiomyopathy I42.00] response.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Dilated cardiomyopathy (I42.00) features subendocardial perfusion deficits [Dilated cardiomyopathy I42.00]. therapeutic stabilization in heart & vascular is verified against Left Ventricular Ejection in Dilated cardiomyopathy (I42.00: Fraction (LVEF)).
Common Symptoms & Clinical Signs
- • Presentation of Dilated cardiomyopathy (I42.00): shortness of breath in Dilated cardiomyopathy (I42.00: when climbing stairs)
- • Secondary Dilated cardiomyopathy clinical sign: palpitations, skipped beats, in Dilated cardiomyopathy (I42.00: or irregular resting)
- • Symptom flares in Dilated cardiomyopathy correlating with Apolipoprotein B (ApoB) [Dilated cardiomyopathy I42.00] deviation outside < 70 mg/dL (I42.00)
- • Functional heart & vascular impact requiring 12-lead resting electrocardiography [Dilated cardiomyopathy I42.00] evaluation (I42.00)
Dilated cardiomyopathy Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I42.00 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Heart & Cardiovascular Disease | NLM Clinical Tables |
| Diagnostic / Lab Marker: Apolipoprotein B (ApoB) [Dilated cardiomyopathy I42.00] | < 70 mg/dL (I42.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Left Ventricular Ejection in Dilated cardiomyopathy (I42.00: Fraction (LVEF)) | 55% – 70% (I42.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: NT-proBNP [Dilated cardiomyopathy I42.00] | < 100 pg/mL (I42.00) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Dilated cardiomyopathy
Treatment selection for Dilated cardiomyopathy depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Dilated cardiomyopathy)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY This study comprises the largest discovery exome-wide and genome-wide association study for atorvastatin- or rosuvastatin-mediated SAMS to date. Circulation. Genomic and precision medicine • 2022-06-15 • Randomized Controlled Trial | N = 18 | 88/100 | PMID 35543701 ↗ |
| Can This Approach Help? Inside the Latest Research on Liraglutide Effects in irregular heartbeat (AFib) (LEAF) Whereas adding liraglutide to RFM in obese patients with AF did not produce significant differences in early weight loss or LAEAT reduction, improved freedom from AF/atrial flutter was noted. JACC. Clinical electrophysiology • 2026-09-15 • Randomized Controlled Trial | N = 28 | 82/100 | PMID 42159524 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in Lipophilic atorvastatin but not hydrophilic rosuvastatin improves cardiac sympathetic nerve activity in CHF patients with DCM. Circulation journal : official journal of the Japanese Circulation Society • 2011-01-15 • Randomized Controlled Trial | N = 32 | 82/100 | PMID 21737951 ↗ |
Dilated cardiomyopathy Patient Community & “People Like Me” Threads
Filter Dilated cardiomyopathy community threads and patient logs by age, biological sex, dosage, and treatment duration.